Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
34 pending office actions • 24 art units • 34 examiners • 0 of 34 (0%) have an AI response strategy ready • 31 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 2 (6%) |
| §103 only | 8 (24%) |
| §112 only | 6 (18%) |
| Double-patenting + other | 2 (6%) |
| Multi-statute (no §101) | 15 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALMO, KHAREEM E | 1 | 87.3% | +5.6% |
| CRANDALL, RICHARD W. | 1 | 30.2% | +33.8% |
| RAHMAN, MASUDUR | 1 | 72.7% | +31.7% |
| HODAC, ERIC KHOI | 1 | 85.2% | +13.5% |
| JUEDES, AMY E | 1 | 44.8% | +41.7% |
| WESTFALL, SARAH ANN | 1 | 0.0% | +0.0% |
| MACCAGNO, PIERRE L | 1 | 23.9% | +30.5% |
| FAUST, AMBER KATHLEEN | 1 | 60.6% | +53.3% |
| YOON, CHANEL J | 1 | 55.0% | +40.1% |
| CESARE, JOSEPH DAVID | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18035399 | VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY | SULLIVAN, DENNIS JOHN | 37d overdue |
| 18015627 | SYSTEMS AND METHODS FOR CELL CAPTURE, BIOMARKER DETECTION, AND CONTACT-FREE CELL LYSIS | LU, FRANK WEI MIN | 16d overdue |
| 18568940 | APPARATUS AND METHOD FOR SURGICAL MARGIN ASSESSMENT USING BIOIMPEDANCE SENSING ARRAY | WESTFALL, SARAH ANN | 1d overdue |
| 18016109 | METHODS AND COMPOSITIONS FOR CRISPR/CAS9 GUIDE RNA EFFICIENCY AND SPECIFICITY AGAINST GENETICALLY DIVERSE HIV-1 ISOLATES | HUDSON, AMY ROSE | 5d |
| 18749826 | Harmonic Radar Scanner for Electronics | HODAC, ERIC KHOI | 12d |
| 18287428 | SYSTEM AND METHOD FOR DETECTION OF HEALTH-RELATED BEHAVIORS | MACCAGNO, PIERRE L | 14d |
| 18901646 | Judicial Support Tool Computing System | CRANDALL, RICHARD W. | 49d |
| 17781406 | TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER | SAMSELL, RILLA MARIE | 78d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18749826 | Harmonic Radar Scanner for Electronics | HODAC, ERIC KHOI | 12d |
| 18287428 | SYSTEM AND METHOD FOR DETECTION OF HEALTH-RELATED BEHAVIORS | MACCAGNO, PIERRE L | 14d |
| 18901646 | Judicial Support Tool Computing System | CRANDALL, RICHARD W. | 49d |
| 18795558 | NUCLEIC ACID CONSTRUCTS FOR CO-EXPRESSION OF CHIMERIC ANTIGEN RECEPTOR AND TRANSCRIPTION FACTOR, CELLS CONTAINING AND THERAPEUTIC USE THEREOF | RAHMAN, MASUDUR | — |
| 18621312 | ANTI-NMDAR2B ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE | JUEDES, AMY E | — |
| 18364503 | ENGINEERED NATURAL LIGAND-BASED CAR: DIRECTED EVOLUTION OF THE STRESS-RECEPTOR NKP30 | FAUST, AMBER KATHLEEN | — |
| 18229086 | OPTICAL TIME-OF-FLIGHT IMAGING METHODS AND SYSTEMS FOR SURGICAL GUIDANCE AND FLUORESCENCE DEPTH ESTIMATION IN TISSUE | YOON, CHANEL J | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 1675 | 2 |
| 3619 | 1 |
| 1633 | 1 |
| 3648 | 1 |
| 3687 | 1 |
| 1643 | 1 |
| 3774 | 1 |
| 1642 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19182783 | SWITCHED-CAPACITOR GATE DRIVER FOR DRIVING CAPACITIVE LOADS | ALMO, KHAREEM E | — | §102§103 | Non-Final OA | — | Pending | Apr 18, 2025 |
| 18901646 | Judicial Support Tool Computing System | CRANDALL, RICHARD W. | 3619 | §101 | Final Rejection | 49d | Pending | Sep 30, 2024 |
| 18795558 | NUCLEIC ACID CONSTRUCTS FOR CO-EXPRESSION OF CHIMERIC ANTIGEN RECEPTOR AND TRANSCRIPTION FACTOR, CELLS CONTAINING AND THERAPEUTIC USE THEREOF | RAHMAN, MASUDUR | 1633 | §102§112 | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18749826 | Harmonic Radar Scanner for Electronics | HODAC, ERIC KHOI | 3648 | §102§103 | Non-Final OA | 12d | Pending | Jun 21, 2024 |
| 18621312 | ANTI-NMDAR2B ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE | JUEDES, AMY E | — | §112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18568940 | APPARATUS AND METHOD FOR SURGICAL MARGIN ASSESSMENT USING BIOIMPEDANCE SENSING ARRAY | WESTFALL, SARAH ANN | 3791 | §103§112 | Final Rejection | 1d overdue | Pending | Dec 11, 2023 |
| 18287428 | SYSTEM AND METHOD FOR DETECTION OF HEALTH-RELATED BEHAVIORS | MACCAGNO, PIERRE L | 3687 | §101§103 | Final Rejection | 14d | Pending | Oct 18, 2023 |
| 18364503 | ENGINEERED NATURAL LIGAND-BASED CAR: DIRECTED EVOLUTION OF THE STRESS-RECEPTOR NKP30 | FAUST, AMBER KATHLEEN | 1643 | §102§103§112 | Non-Final OA | — | Pending | Aug 03, 2023 |
| 18229086 | OPTICAL TIME-OF-FLIGHT IMAGING METHODS AND SYSTEMS FOR SURGICAL GUIDANCE AND FLUORESCENCE DEPTH ESTIMATION IN TISSUE | YOON, CHANEL J | 3791 | §112 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18359373 | IMMUNOSTIMULATORY CYTOKINE COMBINATION AND THERAPEUTIC USE THEREOF | CESARE, JOSEPH DAVID | 1675 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18222275 | DEVICE AND METHOD TO ASSIST REVISION SURGERIES FOR KNEE ARTHROPLASTY | RAMANA, ANURADHA | 3774 | §102§112 | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18035399 | VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY | SULLIVAN, DENNIS JOHN | 1642 | §103§112Other | Non-Final OA | 37d overdue | Pending | May 04, 2023 |
| 18307522 | Methods of Treating Cystic Fibrosis | REDWOOD, CHRISTOPHER EVAN | 1629 | §103 | Non-Final OA | — | Pending | Apr 26, 2023 |
| 18030801 | METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS | MYERS, CARLA J | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 17790245 | METAL PHOSPHOROTHIOATES AND METAL-SULFUR ELECTROCHEMICAL SYSTEM CONTAINING THE SAME | CHOI, EVERETT TIMOTHY | 1751 | §103 | Non-Final OA | — | Pending | Jun 30, 2022 |
| 17782252 | ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION | MATALKAH, FATIMAH KHALAF | 1638 | §112 | Final Rejection | — | Pending | Jun 03, 2022 |
| 17781406 | TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER | SAMSELL, RILLA MARIE | 1624 | §102§112 | Final Rejection | 78d | Pending | Jun 01, 2022 |
| 19058657 | MONOLITHIC THREE-DIMENSIONAL NEURAL PROBES | KIM, EUN HWA | — | §102§103§112 | Non-Final OA | — | Pending | Feb 20, 2025 |
| 18842975 | MULTIMODAL MECHANICAL SENSING WITH DEFORMABLE LIQUID METAL TRANSMISSION LINES | PLUMB, NIGEL H | — | §102§103 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18784881 | INTEGRATED BIOMATERIAL SCAFFOLD WITH 3D PRINTED LATTICE BACKBONE | TRUONG, QUANGLONG N | — | §103 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18703610 | NEOADJUVANT USAGE OF PLANT VIRUS OR VIRUS-LIKE PARTICLES FOR CANCER TREATMENT | FOLEY, SHANON A | — | §103 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18601999 | DESIGN FOR SUPPRESSING ARTIFACTS IN CONCURRENT VOLTAMMETRY AND ELECTROPHYSIOLOGICAL RECORDING | KAUR, GURPREET | 3794 | §103 | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18599832 | METHOD FOR ATTENUATING NEUROINFLAMMATION, AMYLOIDOPATHY AND TAUOPATHY | COUGHLIN, MATTHEW P | 1626 | §103§112DP | Final Rejection | — | Pending | Mar 08, 2024 |
| 18685671 | FUNCTIONALIZATION OF MICROSCALE 3D-PRINTED POLYMER STRUCTURES WITH NANOSCALE VAPOR DEPOSITED ELECTRONIC LAYERS | ROBINSON, MICHAEL | 1787 | §103§112 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18578900 | FLEXIBLE PIEZOELECTRIC ARRAY FOR WEARABLE BLOOD PRESSURE SENSING | EPPERT, LUCY CLARE | 3791 | §103 | Non-Final OA | 31d overdue | Pending | Jan 12, 2024 |
| 18514761 | ENGINEERED NEMO AND USES THEREOF | STOICA, ELLY GERALD | — | §112 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18560179 | LIVER X RECEPTOR MODULATORS | KENYON, JOHN S | 1625 | §112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18551249 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | KUCHARCZK, JED A | 1623 | §102§112 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18468907 | C19 SCAFFOLDS AND STEROIDS AND METHODS OF USE AND MANUFACTURE THEREOF | HERNANDEZ, JACKSON J | 1627 | §103§112DP | Non-Final OA | 30d overdue | Pending | Sep 18, 2023 |
| 18263471 | METHODS FOR INCREASING VIRAL TRANSDUCTION OF CELLS | TAKENAKA, RISA | 1632 | §103 | Final Rejection | 13d | Pending | Jul 28, 2023 |
| 18209941 | Localizing Underwater Robots from the Air | MOORE, WHITNEY | 3646 | §103 | Final Rejection | 118d overdue | Pending | Jun 14, 2023 |
| 18016109 | METHODS AND COMPOSITIONS FOR CRISPR/CAS9 GUIDE RNA EFFICIENCY AND SPECIFICITY AGAINST GENETICALLY DIVERSE HIV-1 ISOLATES | HUDSON, AMY ROSE | 1636 | §102§103 | Non-Final OA | 5d | Pending | Jan 13, 2023 |
| 18015627 | SYSTEMS AND METHODS FOR CELL CAPTURE, BIOMARKER DETECTION, AND CONTACT-FREE CELL LYSIS | LU, FRANK WEI MIN | 1683 | §102§103 | Final Rejection | 16d overdue | Pending | Jan 11, 2023 |
| 17917174 | CROSS-REACTIVE CORONAVIRUS ANTIBODIES AND USES THEREOF | ESSEX, LAURA ANN | 1675 | §112 | Final Rejection | 8d overdue | Pending | Oct 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial